CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core: Canadian Guidelines for Management and Treatment of HIV/Hepatitis C Coinfection in Adults | Zendy

Mark Hull | Zendy; Marina B. Klein | Zendy; Stephen D. Shafran | Zendy; Alice Tseng | Zendy; Pierre Giguère | Zendy; Pierre Côté | Zendy; Marc Poliquin | Zendy; Curtis Cooper | Zendy; on behalf of The CIHR Canadian HIV Trials Network HIV Hepati | Zendy

Open Access

CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core: Canadian Guidelines for Management and Treatment of HIV/Hepatitis C Coinfection in Adults

Author(s) -

Mark Hull,

Marina B. Klein,

Stephen D. Shafran,

Alice Tseng,

Pierre Giguère,

Pierre Côté,

Marc Poliquin,

Curtis Cooper,

on behalf of The CIHR Canadian HIV Trials Network HIV Hepati

Publication year - 2013

Publication title -

canadian journal of infectious diseases and medical microbiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.634

H-Index - 38

eISSN - 1918-1493

pISSN - 1712-9532

DOI - 10.1155/2013/781410

Subject(s) - medicine , coinfection , hepatitis c , context (archaeology) , pegylated interferon , immunology , ribavirin , liver disease , hepatitis c virus , human immunodeficiency virus (hiv) , virus , biology , paleontology

Hepatitis C virus (HCV) coinfection occurs in 20% to 30% of Canadians living with HIV, and is responsible for a heavy burden of morbidity and mortality. HIV-HCV management is more complex due to the accelerated progression of liver disease, the timing and nature of antiretroviral and HCV therapy, mental health and addictions management, socioeconomic obstacles and drug-drug interactions between new HCV direct-acting antiviral therapies and antiretroviral regimens.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research